Provided by Tiger Trade Technology Pte. Ltd.

Neuphoria Therapeutics Inc

3.95
+0.04001.02%
Post-market: 3.950.00000.00%16:00 EDT
Volume:57.93K
Turnover:231.17K
Market Cap:21.35M
PE:-0.80
High:4.01
Open:3.90
Low:3.90
Close:3.91
52wk High:21.40
52wk Low:3.19
Shares:5.40M
Float Shares:4.99M
Volume Ratio:0.55
T/O Rate:1.16%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.9545
EPS(LYR):-0.2278
ROE:-62.90%
ROA:-27.97%
PB:0.73
PE(LYR):-17.34

Loading ...

Analysts Conflicted on These Healthcare Names: HCA Healthcare (HCA), Summit Therapeutics (SMMT) and Neuphoria Therapeutics (NEUP)

TIPRANKS
·
Jul 27

Neuphoria Therapeutics Agrees to All-Share Takeover by Scancell

MT Newswires Live
·
Jul 23

Scancell and Neuphoria Therapeutics Announce Merger Agreement and Financing

Reuters
·
Jul 23

Neuphoria Therapeutics - Scancell to Buy Neuphoria in All-share Merger

THOMSON REUTERS
·
Jul 23

NASDAQ Trade Halt Volatility Trading Pause at 03:20 Pm

Reuters
·
Jul 02

Neuphoria Therapeutics Shares Rise 6% to $4.85 in Light Volume Trading After the Bell, Confirms Talks on Potential Acquisition by Scancell

THOMSON REUTERS
·
Jun 27

Neuphoria Therapeutics - in Talks with Scancell About Possible Combination

THOMSON REUTERS
·
Jun 27

Neuphoria Therapeutics - Confirms Discussions on Potential Acquisition by Scancell, Which Would Become Nasdaq-listed

THOMSON REUTERS
·
Jun 27

Neuphoria Therapeutics confirms merger discussions with Scancell Holdings

TIPRANKS
·
Jun 27

Neuphoria Says it is in Talks with Scancell on Potential Acquisition

Reuters
·
Jun 27

Neuphoria Responds to the announcement made by London-listed Scancell Holdings plc

GlobeNewswire
·
Jun 27

Neuphoria Receives Milestone Revenue From Pfizer KAT6 Trial

TIPRANKS
·
May 27

Neuphoria Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 19

Neuphoria Therapeutics Inc expected to post a loss of $1.12 a share - Earnings Preview

Reuters
·
May 16

Neuphoria Therapeutics (NASDAQ:NEUP) Is In A Strong Position To Grow Its Business

Simply Wall St.
·
Feb 19

Neuphoria Therapeutics posts Q4 income before income taxes of USD 1.83 million, reversing a loss

Reuters
·
Feb 18